0001179110-16-030032.txt : 20160926
0001179110-16-030032.hdr.sgml : 20160926
20160926163735
ACCESSION NUMBER: 0001179110-16-030032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160926
FILED AS OF DATE: 20160926
DATE AS OF CHANGE: 20160926
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kovacs Shane William Charles
CENTRAL INDEX KEY: 0001579397
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 161902631
MAIL ADDRESS:
STREET 1: PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
4
1
edgar.xml
FORM 4 -
X0306
4
2016-09-26
0
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001579397
Kovacs Shane William Charles
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
0
1
0
0
Chief Financial Officer
Common Stock
2016-09-26
4
M
0
10000
10.85
A
18850
D
Stock Option (Right to Buy)
10.85
2016-09-26
4
M
0
10000
0
D
2023-05-21
Common Stock
10000
55625
D
Stock Option (Right to Buy)
27.05
2024-01-27
Common Stock
46384
46384
D
Stock Option (Right to Buy)
51.00
2025-01-01
Common Stock
85600
85600
D
Stock Option (Right to Buy)
30.86
2026-01-03
Common Stock
80000
80000
D
This option award was granted on May 22, 2013, with 25% of the shares underlying the option vested on May 22, 2014, and an additional 2.083% of the original number of shares underlying the option vesting on a monthly basis thereafter, beginning on June 30, 2014.
This option award was granted on January 28, 2014, with 25% of the shares underlying the option vested on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
This option award was granted on January 2, 2015, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
/s/ Colleen Diver Johnson, attorney-in-fact
2016-09-26